25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GNLKQ (Genelink Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Genelink Inc together

I guess you are interested in Genelink Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Genelink Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Genelink Inc’s Price Targets

I'm going to help you getting a better view of Genelink Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Genelink Inc

I send you an email if I find something interesting about Genelink Inc.

1. Quick Overview

1.1. Quick analysis of Genelink Inc (30 sec.)










1.2. What can you expect buying and holding a share of Genelink Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.01
Expected worth in 1 year
$-0.03
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.02
Return On Investment
-17,815.5%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Genelink Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-0.12 - $-0.05
Total Value Per Share
$-0.13 - $-0.06

2.2. Growth of Genelink Inc (5 min.)




Is Genelink Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.6m-$1.4m-$1.1m-44.4%

How much money is Genelink Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3m-$3.8m$778.4k25.5%
Net Profit Margin-142.9%-81.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Genelink Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Genelink Inc?

Welcome investor! Genelink Inc's management wants to use your money to grow the business. In return you get a share of Genelink Inc.

First you should know what it really means to hold a share of Genelink Inc. And how you can make/lose money.

Speculation

The Price per Share of Genelink Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genelink Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genelink Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.01. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genelink Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-11,515.2%-0.01-11,515.2%-0.01-14,452.5%-0.01-11,969.8%-0.01-11,196.9%-0.01-8,063.9%
Usd Book Value Change Per Share0.00-4,453.9%0.00-4,453.9%0.00-2,607.9%0.00-2,416.9%0.00-2,154.4%0.00-867.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-4,453.9%0.00-4,453.9%0.00-2,607.9%0.00-2,416.9%0.00-2,154.4%0.00-867.5%
Usd Price Per Share0.01-0.01-0.06-0.04-0.07-0.14-
Price to Earnings Ratio-0.88--0.88--4.23--3.08--7.04--23.99-
Price-to-Total Gains Ratio-2.27--2.27--23.47--80.92--109.16--59.04-
Price to Book Ratio-1.01--1.01--10.95--8.57-128.30-57.61-
Price-to-Total Gains Ratio-2.27--2.27--23.47--80.92--109.16--59.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10000000 shares)-44,538.69-21,543.51
Gains per Year (10000000 shares)-178,154.77-86,174.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-178155-1781650-86174-86184
20-356310-3563200-172348-172358
30-534464-5344750-258522-258532
40-712619-7126300-344696-344706
50-890774-8907850-430870-430880
60-1068929-10689400-517044-517054
70-1247083-12470950-603218-603228
80-1425238-14252500-689392-689402
90-1603393-16034050-775566-775576
100-1781548-17815600-861740-861750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.014.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%3.011.00.021.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.014.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%3.011.00.021.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Genelink Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.0040%-0.003-41%-0.002-46%-0.002-52%-0.001-81%
Book Value Per Share---0.010-0.0100%-0.006-44%-0.006-38%-0.004-58%-0.002-76%
Current Ratio--0.4200.4200%0.810-48%0.620-32%0.678-38%1.590-74%
Debt To Asset Ratio--2.8292.8290%1.533+85%1.940+46%1.639+73%1.574+80%
Debt To Equity Ratio----0%-0%-0%9.544-100%5.451-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---1280994.019-1280994.0190%12699274.290-110%6734071.533-119%16925128.336-108%34811677.172-104%
Eps---0.012-0.0120%-0.014+26%-0.012+4%-0.011-3%-0.008-30%
Ev To Ebitda Ratio--0.5110.5110%-3.703+825%-2.371+564%-6.951+1461%-24.007+4800%
Ev To Sales Ratio---0.600-0.6000%2.711-122%1.077-156%2.432-125%168.713-100%
Free Cash Flow Per Share---0.010-0.0100%-0.011+12%-0.009-11%-0.009-13%-0.006-42%
Free Cash Flow To Equity Per Share---0.004-0.0040%0.001-460%-0.001-83%-0.001-76%0.000-97%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.036-3%
Intrinsic Value_10Y_max---0.047----------
Intrinsic Value_10Y_min---0.116----------
Intrinsic Value_1Y_max---0.006----------
Intrinsic Value_1Y_min---0.010----------
Intrinsic Value_3Y_max---0.016----------
Intrinsic Value_3Y_min---0.031----------
Intrinsic Value_5Y_max---0.026----------
Intrinsic Value_5Y_min---0.054----------
Market Cap26501.901-10000%2676691.9812676691.9810%16219163.290-83%9920544.866-73%19733315.336-86%36501067.972-93%
Net Profit Margin---1.429-1.4290%-0.818-43%-0.861-40%-0.662-54%-4.172+192%
Operating Margin---1.274-1.2740%-0.761-40%-0.780-39%-0.601-53%-4.253+234%
Operating Ratio--2.6242.6240%1.761+49%1.897+38%1.666+58%4.983-47%
Pb Ratio-0.010+99%-1.006-1.0060%-10.952+989%-8.571+752%128.296-101%57.610-102%
Pe Ratio-0.009+99%-0.877-0.8770%-4.235+383%-3.079+251%-7.039+702%-23.991+2635%
Price Per Share0.000-10000%0.0100.0100%0.061-83%0.037-73%0.074-86%0.138-93%
Price To Free Cash Flow Ratio-0.010+99%-1.019-1.0190%-5.512+441%-4.651+356%-9.456+828%-36.053+3436%
Price To Total Gains Ratio-0.022+99%-2.268-2.2680%-23.467+935%-80.920+3468%-109.165+4714%-59.036+2503%
Quick Ratio--0.1290.1290%0.425-70%0.332-61%0.368-65%1.182-89%
Return On Assets---2.098-2.0980%-1.378-34%-1.669-20%-1.495-29%-1.678-20%
Return On Equity----0%-0%-0%-9.9670%-5.9550%
Total Gains Per Share---0.004-0.0040%-0.003-41%-0.002-46%-0.002-52%-0.001-81%
Usd Book Value---2661353.000-2661353.0000%-1480993.000-44%-1644067.667-38%-1123949.800-58%-635712.800-76%
Usd Book Value Change Per Share---0.004-0.0040%-0.003-41%-0.002-46%-0.002-52%-0.001-81%
Usd Book Value Per Share---0.010-0.0100%-0.006-44%-0.006-38%-0.004-58%-0.002-76%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---1280994.019-1280994.0190%12699274.290-110%6734071.533-119%16925128.336-108%34811677.172-104%
Usd Eps---0.012-0.0120%-0.014+26%-0.012+4%-0.011-3%-0.008-30%
Usd Free Cash Flow---2625573.000-2625573.0000%-2942420.000+12%-2344054.000-11%-2286960.000-13%-1533905.500-42%
Usd Free Cash Flow Per Share---0.010-0.0100%-0.011+12%-0.009-11%-0.009-13%-0.006-42%
Usd Free Cash Flow To Equity Per Share---0.004-0.0040%0.001-460%-0.001-83%-0.001-76%0.000-97%
Usd Market Cap26501.901-10000%2676691.9812676691.9810%16219163.290-83%9920544.866-73%19733315.336-86%36501067.972-93%
Usd Price Per Share0.000-10000%0.0100.0100%0.061-83%0.037-73%0.074-86%0.138-93%
Usd Profit---3051747.000-3051747.0000%-3830196.000+26%-3172222.333+4%-2967385.800-3%-2137086.700-30%
Usd Revenue--2136142.0002136142.0000%4684577.000-54%4886897.000-56%5919917.800-64%3070277.200-30%
Usd Total Gains Per Share---0.004-0.0040%-0.003-41%-0.002-46%-0.002-52%-0.001-81%
 EOD+2 -6MRQTTM+0 -0YOY+9 -263Y+6 -295Y+5 -3110Y+8 -29

3.3 Fundamental Score

Let's check the fundamental score of Genelink Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.009
Price to Book Ratio (EOD)Between0-1-0.010
Net Profit Margin (MRQ)Greater than0-1.429
Operating Margin (MRQ)Greater than0-1.274
Quick Ratio (MRQ)Greater than10.129
Current Ratio (MRQ)Greater than10.420
Debt to Asset Ratio (MRQ)Less than12.829
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.098
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Genelink Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Genelink Inc

GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was founded in 1994 and is based in Orlando, Florida.

Fundamental data was last updated by Penke on 2025-06-29 15:57:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Genelink Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Genelink Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -142.9%Β means thatΒ $-1.43 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genelink Inc:

  • The MRQ is -142.9%. The company is making a huge loss. -2
  • The TTM is -142.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-142.9%TTM-142.9%0.0%
TTM-142.9%YOY-81.8%-61.1%
TTM-142.9%5Y-66.2%-76.7%
5Y-66.2%10Y-417.2%+351.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-142.9%-93.6%-49.3%
TTM-142.9%-140.9%-2.0%
YOY-81.8%-197.6%+115.8%
3Y-86.1%-248.5%+162.4%
5Y-66.2%-343.4%+277.2%
10Y-417.2%-496.2%+79.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Genelink Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Genelink Inc to theΒ Biotechnology industry mean.
  • -209.8% Return on Assets means thatΒ Genelink Inc generatedΒ $-2.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genelink Inc:

  • The MRQ is -209.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -209.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-209.8%TTM-209.8%0.0%
TTM-209.8%YOY-137.8%-72.0%
TTM-209.8%5Y-149.5%-60.3%
5Y-149.5%10Y-167.8%+18.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-209.8%-11.6%-198.2%
TTM-209.8%-11.6%-198.2%
YOY-137.8%-11.4%-126.4%
3Y-166.9%-11.8%-155.1%
5Y-149.5%-12.0%-137.5%
10Y-167.8%-13.7%-154.1%
4.3.1.3. Return on Equity

Shows how efficient Genelink Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Genelink Inc to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Genelink Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genelink Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-996.7%+996.7%
5Y-996.7%10Y-595.5%-401.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--14.9%+14.9%
YOY--14.6%+14.6%
3Y--16.8%+16.8%
5Y-996.7%-17.5%-979.2%
10Y-595.5%-19.9%-575.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Genelink Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Genelink Inc is operatingΒ .

  • Measures how much profit Genelink Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Genelink Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of -127.4%Β means the company generated $-1.27 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genelink Inc:

  • The MRQ is -127.4%. The company is operating very inefficient. -2
  • The TTM is -127.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-127.4%TTM-127.4%0.0%
TTM-127.4%YOY-76.1%-51.3%
TTM-127.4%5Y-60.1%-67.2%
5Y-60.1%10Y-425.3%+365.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-127.4%-232.5%+105.1%
TTM-127.4%-250.5%+123.1%
YOY-76.1%-209.2%+133.1%
3Y-78.0%-234.1%+156.1%
5Y-60.1%-346.1%+286.0%
10Y-425.3%-477.5%+52.2%
4.3.2.2. Operating Ratio

Measures how efficient Genelink Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 2.62 means that the operating costs are $2.62 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Genelink Inc:

  • The MRQ is 2.624. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.624. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.624TTM2.6240.000
TTM2.624YOY1.761+0.863
TTM2.6245Y1.666+0.958
5Y1.66610Y4.983-3.318
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6242.111+0.513
TTM2.6242.694-0.070
YOY1.7613.096-1.335
3Y1.8973.652-1.755
5Y1.6664.745-3.079
10Y4.9836.614-1.631
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Genelink Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Genelink Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.42Β means the company has $0.42 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Genelink Inc:

  • The MRQ is 0.420. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.420. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.420TTM0.4200.000
TTM0.420YOY0.810-0.390
TTM0.4205Y0.678-0.258
5Y0.67810Y1.590-0.912
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4203.661-3.241
TTM0.4203.846-3.426
YOY0.8104.140-3.330
3Y0.6204.688-4.068
5Y0.6785.746-5.068
10Y1.5906.147-4.557
4.4.3.2. Quick Ratio

Measures if Genelink Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Genelink Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.13Β means the company can pay off $0.13 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genelink Inc:

  • The MRQ is 0.129. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.129. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.129TTM0.1290.000
TTM0.129YOY0.425-0.297
TTM0.1295Y0.368-0.240
5Y0.36810Y1.182-0.814
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1292.848-2.719
TTM0.1293.169-3.040
YOY0.4253.786-3.361
3Y0.3324.311-3.979
5Y0.3685.703-5.335
10Y1.1826.368-5.186
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Genelink Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Genelink IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Genelink Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.83Β means that Genelink Inc assets areΒ financed with 282.9% credit (debt) and the remaining percentage (100% - 282.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Genelink Inc:

  • The MRQ is 2.829. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.829. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.829TTM2.8290.000
TTM2.829YOY1.533+1.297
TTM2.8295Y1.639+1.191
5Y1.63910Y1.574+0.065
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8290.329+2.500
TTM2.8290.349+2.480
YOY1.5330.331+1.202
3Y1.9400.340+1.600
5Y1.6390.349+1.290
10Y1.5740.379+1.195
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Genelink Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Genelink Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genelink Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y9.544-9.544
5Y9.54410Y5.451+4.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.379-0.379
TTM-0.437-0.437
YOY-0.414-0.414
3Y-0.450-0.450
5Y9.5440.464+9.080
10Y5.4510.515+4.936
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Genelink Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Genelink Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.88 means the investor is paying $-0.88Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genelink Inc:

  • The EOD is -0.009. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.877. Based on the earnings, the company is expensive. -2
  • The TTM is -0.877. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.009MRQ-0.877+0.868
MRQ-0.877TTM-0.8770.000
TTM-0.877YOY-4.235+3.357
TTM-0.8775Y-7.039+6.161
5Y-7.03910Y-23.991+16.953
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.009-2.356+2.347
MRQ-0.877-2.077+1.200
TTM-0.877-2.574+1.697
YOY-4.235-3.760-0.475
3Y-3.079-3.773+0.694
5Y-7.039-6.193-0.846
10Y-23.991-6.876-17.115
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genelink Inc:

  • The EOD is -0.010. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.019. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.019. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.010MRQ-1.019+1.009
MRQ-1.019TTM-1.0190.000
TTM-1.019YOY-5.512+4.493
TTM-1.0195Y-9.456+8.437
5Y-9.45610Y-36.053+26.597
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.010-3.246+3.236
MRQ-1.019-2.705+1.686
TTM-1.019-3.704+2.685
YOY-5.512-4.402-1.110
3Y-4.651-5.070+0.419
5Y-9.456-8.477-0.979
10Y-36.053-9.305-26.748
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Genelink Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -1.01 means the investor is paying $-1.01Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Genelink Inc:

  • The EOD is -0.010. Based on the equity, the company is expensive. -2
  • The MRQ is -1.006. Based on the equity, the company is expensive. -2
  • The TTM is -1.006. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.010MRQ-1.006+0.996
MRQ-1.006TTM-1.0060.000
TTM-1.006YOY-10.952+9.946
TTM-1.0065Y128.296-129.301
5Y128.29610Y57.610+70.686
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0102.038-2.048
MRQ-1.0061.843-2.849
TTM-1.0062.125-3.131
YOY-10.9522.442-13.394
3Y-8.5712.492-11.063
5Y128.2963.652+124.644
10Y57.6104.311+53.299
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2008-12-312009-12-312010-12-312011-12-312012-12-31
Total Other Income Expense Net -370116-25523-232-32-264681417



6.2. Latest Balance Sheet

Balance Sheet of 2012-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,455
Total Liabilities4,116
Total Stockholder Equity-2,661
 As reported
Total Liabilities 4,116
Total Stockholder Equity+ -2,661
Total Assets = 1,455

Assets

Total Assets1,455
Total Current Assets772
Long-term Assets683
Total Current Assets
Cash And Cash Equivalents 158
Net Receivables 78
Inventory 394
Other Current Assets 142
Total Current Assets  (as reported)772
Total Current Assets  (calculated)772
+/-0
Long-term Assets
Property Plant Equipment 258
Intangible Assets 55
Other Assets 370
Long-term Assets  (as reported)683
Long-term Assets  (calculated)683
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,839
Long-term Liabilities2,277
Total Stockholder Equity-2,661
Total Current Liabilities
Short-term Debt 1,090
Short Long Term Debt 1,090
Accounts payable 1,019
Other Current Liabilities 648
Total Current Liabilities  (as reported)1,839
Total Current Liabilities  (calculated)3,847
+/- 2,008
Long-term Liabilities
Long term Debt 1,090
Other Liabilities 1,188
Deferred Long Term Liability 350
Long-term Liabilities  (as reported)2,277
Long-term Liabilities  (calculated)2,627
+/- 350
Total Stockholder Equity
Common Stock2,577
Retained Earnings -27,612
Other Stockholders Equity 22,374
Total Stockholder Equity (as reported)-2,661
Total Stockholder Equity (calculated)-2,661
+/-0
Other
Cash and Short Term Investments 158
Common Stock Shares Outstanding 214,447
Current Deferred Revenue171
Liabilities and Stockholders Equity 1,455
Net Debt -158
Net Tangible Assets -2,716
Net Working Capital -1,067



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
> Total Assets 
86
127
365
319
1,212
565
445
548
1,384
2,545
1,881
1,721
2,780
1,455
1,4552,7801,7211,8812,5451,3845484455651,21231936512786
   > Total Current Assets 
31
74
286
145
1,007
271
89
202
1,023
1,942
1,299
1,045
1,859
772
7721,8591,0451,2991,9421,023202892711,0071452867431
       Cash And Cash Equivalents 
6
14
121
31
746
156
15
150
972
435
197
429
741
158
1587414291974359721501515674631121146
       Net Receivables 
1
2
1
3
44
23
33
32
35
714
466
306
235
78
7823530646671435323323443121
       Inventory 
11
10
10
26
20
20
3
6
4
740
495
224
562
394
394562224495740463202026101011
       Other Current Assets 
13
47
153
85
197
73
37
14
11
54
141
87
321
142
142321871415411143773197851534713
   > Long-term Assets 
55
53
80
174
205
294
357
346
361
603
582
676
920
683
683920676582603361346357294205174805355
       Property Plant Equipment 
51
50
56
71
70
97
148
132
38
282
303
256
168
258
25816825630328238132148977071565051
       Intangible Assets 
3
2
0
0
0
0
0
0
0
0
264
241
236
55
552362412640000000023
       Long-term Assets Other 
1
1
24
103
134
197
209
215
45
321
279
179
134
370
370134179279321452152091971341032411
> Total Liabilities 
510
825
516
681
471
765
1,058
1,408
1,190
2,493
2,621
2,511
4,261
4,116
4,1164,2612,5112,6212,4931,1901,4081,058765471681516825510
   > Total Current Liabilities 
480
782
100
296
102
332
464
1,109
702
2,493
1,727
1,660
2,296
1,839
1,8392,2961,6601,7272,4937021,109464332102296100782480
       Short-term Debt 
233
449
0
0
0
214
28
18
18
60
36
28
1,170
1,090
1,0901,170283660181828214000449233
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
36
851
1,170
1,090
1,0901,170851360000000000
       Accounts payable 
102
132
89
275
47
96
429
366
439
2,034
1,190
860
1,371
1,019
1,0191,3718601,1902,034439366429964727589132102
       Other Current Liabilities 
128
201
12
21
55
22
7
710
263
398
501
617
717
648
648717617501398263710722552112201128
   > Long-term Liabilities 
31
43
416
386
369
433
593
298
488
0
893
851
1,965
2,277
2,2771,96585189304882985934333693864164331
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,188
1,1881,000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
146
488
350
35048814600000000000
> Total Stockholder Equity
-424
-698
-151
-362
740
-199
-613
-859
193
52
-740
-790
-1,481
-2,661
-2,661-1,481-790-74052193-859-613-199740-362-151-698-424
   Common Stock
106
129
168
191
310
331
367
417
667
1,046
1,189
1,554
2,049
2,577
2,5772,0491,5541,1891,046667417367331310191168129106
   Retained Earnings -27,612-24,560-20,730-18,002-15,285-12,682-11,121-10,536-9,484-7,369-6,189-4,718-3,836-2,940
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
2,410
4,227
5,169
5,826
6,568
6,320
6,595
6,833
7,963
14,292
16,074
14,700
21,030
22,374
22,37421,03014,70016,07414,2927,9636,8336,5956,3206,5685,8265,1694,2272,410



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2012-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,136
Cost of Revenue-1,671
Gross Profit465465
 
Operating Income (+$)
Gross Profit465
Operating Expense-3,934
Operating Income-3,469-3,469
 
Operating Expense (+$)
Research Development251
Selling General Administrative3,442
Selling And Marketing Expenses0
Operating Expense3,9343,693
 
Net Interest Income (+$)
Interest Income0
Interest Expense-331
Other Finance Cost-331
Net Interest Income0
 
Pretax Income (+$)
Operating Income-3,469
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,052-3,886
EBIT - interestExpense = -3,052
-3,052
-2,721
Interest Expense331
Earnings Before Interest and Taxes (EBIT)-2,721-2,721
Earnings Before Interest and Taxes (EBITDA)-2,508
 
After tax Income (+$)
Income Before Tax-3,052
Tax Provision-0
Net Income From Continuing Ops-3,052-3,052
Net Income-3,052
Net Income Applicable To Common Shares-3,052
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses5,605
Total Other Income/Expenses Net4170
 

Technical Analysis of Genelink Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genelink Inc. The general trend of Genelink Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genelink Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Genelink Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genelink Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Know someone who trades $GNLKQ? Share this with them.πŸ‘‡

Genelink Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genelink Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genelink Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genelink Inc. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genelink Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Genelink Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Genelink Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Genelink Inc Daily Moving Average Convergence/Divergence (MACD) ChartGenelink Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genelink Inc. The current adx is 0.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is 0/(-7 +7).

  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Genelink Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genelink Inc. The current sar is 0.0001.

Genelink Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genelink Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Genelink Inc Daily Relative Strength Index (RSI) ChartGenelink Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genelink Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genelink Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Genelink Inc Daily Stochastic Oscillator ChartGenelink Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genelink Inc. The current cci is -66.66666667.

Genelink Inc Daily Commodity Channel Index (CCI) ChartGenelink Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genelink Inc. The current cmo is 0.

Genelink Inc Daily Chande Momentum Oscillator (CMO) ChartGenelink Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genelink Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Genelink Inc Daily Williams %R ChartGenelink Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Genelink Inc.

Genelink Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genelink Inc. The current atr is 0.

Genelink Inc Daily Average True Range (ATR) ChartGenelink Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genelink Inc. The current obv is 0.

Genelink Inc Daily On-Balance Volume (OBV) ChartGenelink Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genelink Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Genelink Inc Daily Money Flow Index (MFI) ChartGenelink Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genelink Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Genelink Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genelink Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Genelink Inc with someone you think should read this too:
  • Are you bullish or bearish on Genelink Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genelink Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genelink Inc

I send you an email if I find something interesting about Genelink Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Genelink Inc.

Receive notifications about Genelink Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.